To wary parents, physicians stress that childhood vaccinations have a long, successful record of preventing diseases, with the benefits far outweighing any risks.
vaccine
Posted inNation & World, Uncategorized
Paul Parkman, an inventor of the rubella vaccine, dies at 91
He trained as a pediatrician but was drawn into virology while serving in the Army Medical Corps in the early 1960s.
advertisement
Posted inHealth
Health officials push to get schoolchildren vaccinated as more U.S. parents opt out
Parents are opting out of school vaccinations at the highest rate ever.
Posted inNation & World, News
The hunt quickens for vaccines and antibody therapies against opioids
Clinical trials are ongoing into a monoclonal antibody treatment for methamphetamine, the stimulant increasingly being used with fentanyl.
Posted inHealth, Local & State
New COVID-19 vaccines arrive in Maine, but supplies will grow next week
The vaccine is recommended for everyone ages 6 months and older and some pharmacies are offering limited appointments for the shots.
Posted inBusiness, Health, Nation & World
Moderna poised to seek flu shot approval after trial results
In a trial on over 2,400 adults, the reformulated shot produced a stronger immune response against all four strains of the influenza virus than a traditional flu vaccine, the company said.
Posted inOp-eds, Opinion
Commentary: The U.S. bungled COVID vaccine distribution. Why no accountability?
There has been no comprehensive debrief on how federal and local governments messed this up.
Posted inOp-eds, Opinion
Commentary: Robert F. Kennedy Jr. is a threat to your health – and our democracy
Will the dazzlement of the Kennedy name be sufficient to blind voters to his history of misrepresentations and outright lies?
Posted inBusiness, Health, Nation & World
FDA advisers back RSV vaccine for pregnant women that protects their newborns
If the FDA ultimately approves the maternal shot, it would mark a second milestone in the decades-long quest to prevent the respiratory syncytial virus.
Posted inNation & World, News
FDA approves second omicron booster for people at high risk from COVID
The shots would be available for people who are at least 65 years old or immune-compromised.